Phospholipase A2 Activating Peptide
CAS No. 137314-60-4
Phospholipase A2 Activating Peptide( ——— )
Catalog No. M42207 CAS No. 137314-60-4
Phospholipase A2 Activating Peptide
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhospholipase A2 Activating Peptide
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhospholipase A2 Activating Peptide
-
DescriptionPhospholipase A2 Activating Peptide
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number137314-60-4
-
Formula Weight2330.8
-
Molecular FormulaC106H184N28O30
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Clobetasone butyrate
Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic?dermatitis and psoriasis.
-
Rhamnetin 3-galactos...
Rhamnetin 3-galactoside is a natural product for research related to life sciences.
-
Syk Inhibitor II hyd...
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.
Cart
sales@molnova.com